Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer
Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer
Recruiting · NCT07501650 · Registry updated 2026-03-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer | Disease Attributes, Head and Neck Neoplasms, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, head and neck cancer, neoplasm | Recruiting | Phase 1 | 2026-03-30 | NCT07501650 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Lantheus Medical Imaging | 15 |
| Thomas Jefferson University | 115 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Philadelphia | United States | 5 |